Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $7.1600 (-9.37%) ($7.1600 - $7.1600) on Thu. Feb. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.9% (three month average) | RSI | 66 | Latest Price | $7.1600(-9.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -1.2% a day on average for past five trading days. | Weekly Trend | CEMI advances 8.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) VXX(12%) XLC(-36%) UNG(-12%) VWO(-21%) XBI(-25%) | Factors Impacting CEMI price | CEMI will decline at least -2.45% in a week (0% probabilities). XRT(-13%) ICLN(-34%) IDRV(-31%) INDA(-46%) IPO(-40%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.45% (StdDev 4.9%) | Hourly BBV | -2.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $7.66(-6.53%) | 10 Day Moving Average | $7.44(-3.76%) | 20 Day Moving Average | $6.88(4.07%) | To recent high | -9.8% | To recent low | 42.2% | Market Cap | $144m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |